✦ LIBER ✦

Use of 90Y-ibritumomab tiuxetan in non-Hodgkin’s lymphoma

✍ Scribed by Robert Marcus

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biodistribution, radiation dosimetry and

✍ Saiyada N. F. Rizvi; Otto J. Visser; Maria J. W. D. Vosjan; Arthur van Lingen; O 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 284 KB

Efficacy and safety of 90Y ibritumomab t

✍ Thomas E Witzig 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

90Y-ibritumomab tiuxetan: Rationale for

✍ Antonio J. Grillo-López 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Radioimmunotherapy in Non-Hodgkin's Lymp

✍ Evens, Andrew M.; Gordon, Leo I. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB

Ongoing Trials with Yttrium 90–Labeled I

✍ Micallef, Ivana N.M. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 366 KB

Radioisotopic Localization of90Yttrium–I

✍ S. A. Jacobs; A. M. Harrison; S. H. Swerdlow; K. A. Foon; N. Avril; N. Vidnovic; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 589 KB